Gene therapy denied for Afghan refugee whose father aided U.S.
Orchard Therapeutics' Libmeldy is on the market in Europe, but Medicaid refused to cover the therapy because it's not approved in the U.S.
Source: statnews.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Storage Disease Program. Real-time updates on events, politics, business and more.